tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CNS Pharmaceuticals to present on TPI 287 at Brain Tumor Biotech Summit
PremiumThe FlyCNS Pharmaceuticals to present on TPI 287 at Brain Tumor Biotech Summit
2M ago
CNS Pharmaceuticals price target raised to $7 from $4 at Alliance Global Partners
Premium
The Fly
CNS Pharmaceuticals price target raised to $7 from $4 at Alliance Global Partners
3M ago
CNS Pharmaceuticals reports Q1 EPS ($1.58) vs. ($1,020.48) last year
Premium
The Fly
CNS Pharmaceuticals reports Q1 EPS ($1.58) vs. ($1,020.48) last year
3M ago
CNS Pharmaceuticals Advances TPI 287 for Glioblastoma
PremiumCompany AnnouncementsCNS Pharmaceuticals Advances TPI 287 for Glioblastoma
4M ago
CNS Pharmaceuticals reports FY24 EPS ($38.87) vs. ($12,509.11) last year
Premium
The Fly
CNS Pharmaceuticals reports FY24 EPS ($38.87) vs. ($12,509.11) last year
4M ago
CNS Pharmaceuticals sees cash runway into 1Q26
Premium
The Fly
CNS Pharmaceuticals sees cash runway into 1Q26
4M ago
CNS Pharmaceuticals down 55% after Berubicin doesn’t show OS superiority in GBM
PremiumThe FlyCNS Pharmaceuticals down 55% after Berubicin doesn’t show OS superiority in GBM
5M ago
Morning Movers: Mobileye jumps following Volkswagen ADAS partnership
Premium
The Fly
Morning Movers: Mobileye jumps following Volkswagen ADAS partnership
5M ago
CNS Pharmaceuticals downgraded to Hold from Buy at Maxim
Premium
The Fly
CNS Pharmaceuticals downgraded to Hold from Buy at Maxim
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100